Agenda – European Artificial Intelligence Innovation Summit

  • Day One
  • Day Two

Day One

 Monday, 5 March

9:00 – 9:15

Chairperson’s Opening Remarks
Ron Alfa, M.D., Ph.D., Vice President, Discovery and Product, RECURSION PHARMA

 Legal Implementation Challenges

9:15 – 10:00

Address the Three Pressing Challenges of AI to Society (and How to Solve Them)
Catelijne Muller, Advisor, EU AFFAIRS AND POLICY; Rapporteur on Artificial Intelligence, EUROPEAN ECONOMIC AND SOCIAL COMMITTEE

10:00 – 10:45

Define the Ethical Responsibility for Data in AI Innovation
Eerke Boiten, Professor of Cyber Security, Cyber Technology Institute, School of Computer Science and Informatics, DE MONTFORT UNIVERSITY

10:45 – 11:15

Networking Break

11:15 – 12:00

Address Legal and Policy Issues Related to the Implementation of AI in Healthcare
Mélanie Bourassa Forcier, Ph.D., Associate Professor, Director, Law and Health Policy Programme, Director, Law and Life Sciences Programme, Law Faculty, UNIVERSITÉ DE SHERBROOKE

12:00 – 12:45

Facilitate Innovation While Achieving Regulatory Compliance in Healthcare
Jonathan Wilkinson, J.D., Privacy Officer, IBM WATSON HEALTH

12:45 – 13:45

Lunch

 Machine Learning for Healthcare

13:45 – 14:30

Transform Healthcare Delivery Through AI
William D. Paiva, Ph.D., Executive Director, Centre for Health Systems Innovation (CHSI), OKLAHOMA STATE UNIVERSITY

14:30 – 15:15

Use AI Systems to Build a Living Hospital
Iain Hennessey, MBCHB, Clinical Director of Innovation, ALDER HEY CHILDREN’S HOSPITAL

15:15 – 15:45

Networking Break

15:45 – 16:30

Promote Healthy Behaviours Through Applications of AI
Alexandru Matei, Data Science Manager, NUFFIELD HEALTH

16:30 – 17:15

Utilise Optimal Engagement Technology to Deliver Evidence-Based Diabetes Programme
Osama Hamdy, M.D., Ph.D., FACE, Medical Director, Obesity Clinical Programme and Director of Inpatient Diabetes Programme, JOSLIN DIABETES CENTRE; Associate Professor of Medicine, HARVARD MEDICAL SCHOOL

17:15 – 18:00

Discuss the Ethical, Moral, and Legal Dimensions of AI and Artificial Life
Agoston E. Eiben, Head, Computational Intelligence Group, Department of Computer Science, Vrije Universteit Amsterdam


Day Two

 Tuesday, 6 March

8:45 – 9:00

Chairperson’s Recap of Day One
Ron Alfa, M.D., Ph.D., Vice President, Discovery and Product, RECURSION PHARMA

 Machine Learning for Life Sciences

9:45 – 10:30

Machine Learning for Smarter Drug Discovery
Claus Bendtsen, Executive Director and Head of Quantitative Biology, ASTRAZENECA

10:30 – 11:00

Networking Break

11:45 – 12:30

Case Study of NIHR HIC: Experiences With Little Big Data
Simon Ashworth, Head, Specialty Critical Care, IMPERIAL COLLEGE LONDON

12:30 – 13:30

Luncheon

13:30 – 14:15

Re-Imaging Drug Discovery Through AI
Ron Alfa, M.D., Ph.D., Vice President, Discovery and Product, RECURSION PHARMA

14:15 – 15:00

Address Drug Development Operational Challenges Through AI
Subrata Bose, Global Head Clinical Trials Analytics and Insights, BAYER

15:00 – 15:15

Chairperson’s Closing Remarks
Ron Alfa, M.D., Ph.D., Vice President, Discovery and Product, RECURSION PHARMA